School prevalence of stimulant therapy for ADHD associated with higher rates of prescription stimulant misuse among teens

NIH study signals importance of monitoring and screening for prescription stimulant misuse in schools [] [View as webpage / Share]( [NIH National Institute on Drug Abuse] NEWS [Teenage students sitting in the classroom taking an exam.] School prevalence of stimulant therapy for ADHD associated with higher rates of prescription stimulant misuse among teens Researchers have identified a strong association between prevalence of prescription stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) and rates of prescription stimulant misuse (taken in a way other than as directed by a clinician) by students in middle and high schools. [The study](, which appeared today in JAMA Network Open, highlights the need for assessments and education in schools and communities to prevent medication-sharing among teens. This is especially important considering non-medical use of prescription stimulants among teens [remains more prevalent]( than misuse of any other prescription drug, including opioids and benzodiazepines. [View Press Release]( Stay Connected [facebook]([twitter]([linkedin]([youtube]( --------------------------------------------------------------- View topics of interest, update your subscriptions, modify your password or email address, alter frequency of bulletins, or stop subscriptions at any time on your [Subscriber Preferences Page](. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit [subscriberhelp.govdelivery.com](. This service is provided to you at no charge by [National Institute on Drug Abuse](. --------------------------------------------------------------- This email was sent to {EMAIL} using govDelivery Communications Cloud on behalf of National Institutes of Health: National Institute on Drug Abuse · 3WFN MSC 6024 · 16071 Industrial Dr ·Dock 11 · Gaithersburg, MD 20877 [GovDelivery logo](